Etramp5 as a useful serological marker in children to assess the immediate effects of mass drug campaigns for malaria.

Thomas DruetzL van den HoogenG StresmanV JosephK E S HamreC FayetteF MonestimeJ PresumeI RomilusG MondélusT ElisméS CooperD ImpoinvilR A AshtonE RogierA ExisteJ BoncyM A ChangJ F LemoineC DrakeleyT P Eisele

Published in: BMC infectious diseases (2022)

Serological markers can be used to evaluate the effects of interventions against malaria on the risk of infection in settings of low transmission. Antibody responses against Etramp5 antigen 1 in Haitian children were reduced in the 2-6 weeks following a tMDA campaign, confirming its usefulness as a short-term marker in child populations.

Keyphrases

young adults
plasmodium falciparum
mental health
physical activity
emergency department
gestational age